ZIVO Bioscience Total Liabilities 2016-2024 | ZIVO

ZIVO Bioscience total liabilities from 2016 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

ZIVO Bioscience Total Liabilities 2016-2024 | ZIVO

ZIVO Bioscience total liabilities from 2016 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$168.1B
Vertex Pharmaceuticals (VRTX)$119.2B
Regeneron Pharmaceuticals (REGN)$113.7B
Gilead Sciences (GILD)$102.4B
Bristol Myers Squibb (BMY)$101.3B
CSL (CSLLY)$95.4B
GSK (GSK)$84.1B
Alnylam Pharmaceuticals (ALNY)$35B
Argenex SE (ARGX)$32.8B
Biogen (BIIB)$27.5B
BioNTech SE (BNTX)$27.5B
Moderna (MRNA)$24.5B
BeiGene (BGNE)$20.1B
Illumina (ILMN)$20.1B
Genmab (GMAB)$15.8B
BioMarin Pharmaceutical (BMRN)$13.1B
Vaxcyte (PCVX)$12.7B
Exact Sciences (EXAS)$12.5B
Insmed (INSM)$12.5B
Incyte (INCY)$12.2B
Bio-Techne Corp (TECH)$11.9B
Sarepta Therapeutics (SRPT)$11.9B
QIAGEN (QGEN)$10.1B
Bio-Rad Laboratories (BIO.B)$9.1B
Roivant Sciences (ROIV)$8.7B
Ascendis Pharma (ASND)$8.5B
Legend Biotech (LEGN)$7.9B
Intra-Cellular Therapies (ITCI)$7.9B
Repligen (RGEN)$7.8B
Exelixis (EXEL)$7.4B